Our approach during the current stage of the COVID19 global pandemic
QinetiQ is committed to the health and wellbeing of our people and we are continuously monitoring the COVID-19 situation, providing information and advice as it becomes available.
In light of the increased measures in place around the world to stop the spread of this disease we have updated our approach to safeguarding our people and their families, whilst continuing to deliver our obligations as a company that provides products and services critical to national defence, security and stability.
For the foreseeable future, employees have been advised only to travel internationally if their trip is critical; to work from home if their job allows; and to increase their use of virtual meetings.
We recognise that we must continue delivering for our customers and help them maintain national requirements for defence and security around the world, especially in these troubling times. This means some teams will continue to work on site to support critical customer programmes. In those cases, our approach is being managed on a case by case basis through our recognised business continuity procedure, where we are working through the potential impact – with a focus on critical facilities, support infrastructure, supply chain, and our people – and putting in place associated mitigation and contingency plans where appropriate.
As we work through these challenges and uncertainties, we continue to support our employees by providing them with access to relevant information and timely advice.
We will update this web page with further information if the situation develops and further changes are required.
Dstl Awards £300m Weapons Sector Research Framework (WSRF) Contract to QinetiQ
28 Jul 2020
QinetiQ Achieves UK’s First Airborne Manned/Unmanned Team Demonstration
22 Jul 2020
QinetiQ Wins Contract to Scope Upgrade to Royal Canadian Air Force Ranges
14 Jul 2020
First Quarter Trading Update and Acquisition of Naimuri
14 Jul 2020
QinetiQ enters next phase of growth in the US
13 Jul 2020